SYNEDGEN, INC.
Doing business as SYNEDGEN INC
- CLAREMONT, CA 91711-3583
- synedgen.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM expired
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $21.1M
- Awards on record
- 2
- Contract vehicles
- 0
- Verified credentials
- 0
SAM.gov registration expired
The registration expired on Nov 11, 2026. Federal awards require an active SAM.gov registration (FAR 4.1102), so confirm renewal before proposing this company as a team member.
View on SAM.gov (opens in a new tab)Learn more about SAM registration and the UEI
About SYNEDGEN, INC.
- Headquarters
- CLAREMONT, CA 91711-3583
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIHX79BD6YQ521
- CAGE5JGC8
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $21.1M
- Awards on record
- 2
- Top funding agencies
- Office of Assistant Secretary for Preparedness and Response · Defense Health Agency
Awards
75A50124C00047
Recompete 6–12 mo: Potential end May 31, 2027 (6 months away)ADVANCE THE DEVELOPMENT OF PAAG17G (DRUG PRODUCT: MIIST305), A ONCE DAILY, ORALLY ADMINISTERED, GUT-RESTRICTED DRUG, TO REDUCE MORTALITY…
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $18.8M
- Period of performance
- Sep 30, 2024 – May 31, 2027
HT942524C0049
Completed: Period of performance ended Sep 19, 2026SBIR PHASE III PROPOSAL NO. JW230017 TITLED, "OPTIMIZED, FIELD-STABLE GLYCOPOLYMER-MIMICKING POLYSACCHARIDE TO PREVENT MORBIDITY AND…
Department of Defense · Defense Health Agency
- Obligated
- $2.3M
- Period of performance
- Sep 20, 2024 – Sep 19, 2026
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75A50124C00047 ADVANCE THE DEVELOPMENT OF PAAG17G (DRUG PRODUCT: MIIST305), A ONCE DAILY, ORALLY ADMINISTERED, GUT-RESTRICTED DRUG, TO REDUCE MORTALITY… | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 541715 · AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $18.8M | Sep 30, 2024 – May 31, 2027 | Recompete 6–12 mo: Potential end May 31, 2027 (6 months away)AI brief for award 75A50124C00047Bid team for the recompete of award 75A50124C00047 |
HT942524C0049 SBIR PHASE III PROPOSAL NO. JW230017 TITLED, "OPTIMIZED, FIELD-STABLE GLYCOPOLYMER-MIMICKING POLYSACCHARIDE TO PREVENT MORBIDITY AND… | Department of Defense · Defense Health Agency | 541715 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $2.3M | Sep 20, 2024 – Sep 19, 2026 | Completed: Period of performance ended Sep 19, 2026 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 10 awards
- Total awarded
- $4,900,995
- By phase
- SBIR Phase I: 7
- SBIR Phase II: 3
- By agency
- Department of Health and Human Services: 7
- Department of Defense: 3
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2020: 1
- 2016: 1
- 2015: 1
- 2014: 2
- 2013: 2
- 2011: 1
- 2010: 1
- 2009: 1
Awards (most recent first)
Development of Technologies that Control Scar Formation after Burn Injuries
SBIR Phase II · Department of Defense (Defense Health Agency) · 2020 · $1,000,000
Mar 2, 2020 – Jul 1, 2021
Solicitation 12.2 (2012) · Topic DHP12-016
Novel treatment for Crohn's disease and related inflammatory gastrointestinal disease
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $224,412
May 1, 2016 – Apr 30, 2017
Solicitation PA15-269 (2016) · Topic 300
Prevention and treatment of GI obstruction syndromes in cystic fibrosis
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $146,412
Aug 1, 2015 – Feb 28, 2017
Solicitation PA14-071 (2015) · Topic 300
Effective New Topical Treatment to Reduce Scar Formation in Burns
SBIR Phase II · Department of Defense (Defense Health Agency) · 2014 · $870,530
Sep 26, 2014 – Feb 25, 2016
Solicitation 2012.2 (2012) · Topic DHP12-016 · Research partner: Stub
Clinical Development of IPdR for Radiosensitization Period of Performance: 09/19/2014 - 06/18/2015
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $196,707
Solicitation year 2014 · Topic NCI · Research partner: Stub
Effective New Topical Treatment to Reduce Scar Formation in Burns
SBIR Phase I · Department of Defense (Defense Health Agency) · 2013 · $149,904
May 30, 2013 – Dec 31, 2013
Solicitation 2012.2 (2012) · Topic DHP12-016
Rectal Medication Administration Device for Palliative Care
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $149,901
Solicitation PA12-088 (2013) · Topic NHLBI · Research partner: Stub
Antimicrobial and Regenerative Treatment for Oral Mucositis
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2011 · $1,963,826
Solicitation PA10-050 (2011) · Topic NIDCR · Research partner: Stub
Wound Decontamination for the Prevention and Treatment of Multi-drug Resistant Ba
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2010 · $99,638
Solicitation PHS2010-2 (2010) · Topic NIAID
Prevention and Treatment of Oral Biofilms and Related Oral Disease by Soluble Chi
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2009 · $99,665
Solicitation PHS2009-2 (2009)
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
No active exclusion on record (checked Nov 14, 2026).
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · as of Nov 14, 2026
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 14, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 14, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Primary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with SYNEDGEN, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
